United States· US:72789-131_2c2501a6-a6d6-1d6c-e063-6294a90ad428

Acarbose

A acarbose product containing acarbose, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 13 of our 19 countries.

ATC A10BF01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAcarboseATCA10BF01REGISTER NO.US:72789-131_2c2501a6…PACKS LISTED3CHECKEDSeptember 12, 2026

Where it is registered

Acarbose is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BF01 (acarbose), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Acarbose · ATC A10BF01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Japan
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acarbose costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.52 in Spain to $1.01 in United States — a ×1.9 gap.

  • United States: $1.01 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Acarbose · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • US United States$1.01 (acquisition cost)
  • IT Italy$0.96
  • FR France$0.65
  • ES Spain$0.52
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Acarbose
Manufacturer
PD-Rx Pharmaceuticals, Inc.
Country
United States (US)
ATC code
A10BF01
ATC class
Acarbose
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 3

  • ndc11
    7278913130
    30 TABLET in 1 BOTTLE, PLASTIC (72789-131-30)
  • ndc11
    7278913160
    60 TABLET in 1 BOTTLE, PLASTIC (72789-131-60)
  • ndc11
    7278913190
    90 TABLET in 1 BOTTLE, PLASTIC (72789-131-90)

Regulatory notes

UNII (FDA substance ID)
T58MSI464G
ACARBOSE
RxCUI 16681
Orange Book
A078470
ABABAB
DailyMed SPL labels
1 version tracked

Interactions

461 interactions on record for acarbose.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acarbose · interactions on record

461 records

  • 8 severe
  • 262 moderate
  • 46 minor
  • 145 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • GatifloxacinJ01MA16severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acarbose in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acarbose products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Bulgaria · Ароба
  • Czechia · Acarbose Viatris
  • Germany · Acarbose Al, Acarbose Dura
  • Spain · Acarbosa Farmalider, Acarbosa Qualigen
  • France · Acarbose Arrow, Acarbose Arrow Lab
  • United Kingdom (Northern Ireland) · Acarbose, Acarbose Generics [uk] Ltd
  • Italy · Acarbosio Aurobindo, Acarbosio Doc Generici
  • Poland · Acarbose Aurovitas, Adeksa
  • Portugal · Acarbose Berar Laboratórios Basi - Indústria Farmacêutica, Acarbose Bluepharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb2dbe29-0465-4975-b3ed-0cf4225bb15f
GET /v1/drugs/bb2dbe29-0465-4975-b3ed-0cf4225bb15f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "T58MSI464G",
    "rxcui": "16681",
    "inchikey": "CEMXHAPUFJOOSV-XGWNLRGSSA-N",
    "display_name": "ACARBOSE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 2
  },
  "spl_meta": {
    "d1b627e1-d78d-47dd-93f5-2bf4998466ba": {
      "match": "brand_token",
      "title": "ACARBOSE TABLET [CHARTWELL RX, LLC]",
      "spl_version": "3",
      "published_date": "2025-12-10"
    }
  },
  "productid": "72789-131_2c2501a6-a6d6-1d6c-e063-6294a90ad428",
  "productndc": "72789-131",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "078470",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "25MG",
        "product_no": "001",
        "approval_date": "May 7, 2008"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "50MG",
        "product_no": "002",
        "approval_date": "May 7, 2008"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "100MG",
        "product_no": "003",
        "approval_date": "May 7, 2008"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ACARBOSE",
  "proprietary_name": "Acarbose",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA078470",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Acarbose",
  "start_marketing_date": "20080507",
  "active_numerator_strength": "25"
}

See everything about acarbose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.